Search results
Indian Startup 3D Prints Rocket Engine in Just 72 Hours - Slashdot
Slashdot· 1 day agoWhile other companies like Relativity Space and Rocket Lab are using 3-D printers extensively, Agnikul's engine is unique in being printed in one go, rather than as multiple ...
EMEA Morning Briefing: Stocks Seen Muted as Focus Shifts to Fed, U.S. Econ Data
Morningstar· 4 days agoEuropean stocks may be little moved at the start of trading on Tuesday ahead of the much-anticipated Federal Reserve meeting. Major U.S. indexes are holding at or near records ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 days agoDouble-blind, placebo-controlled study aims to measure safety and efficacy of INDV-2000 over 3 months in participants with moderate to severe Opioid Use Disorder. INDV-2000 is an investigational ...
Bank of Nova Scotia Has $600,000 Stake in Federal Realty Investment Trust (NYSE:FRT)
ETF DAILY NEWS· 6 days agoBank of Nova Scotia lifted its stake in Federal Realty Investment Trust (NYSE:FRT – Free Report) by 15.8% in the fourth quarter, according to its most recent disclosure with the Securities and ...
Global Startup Ecosystem Report 2024 Showcases Surging Investment in Generative AI
Digital Journal· 5 days agoTransaction in Own Shares - June 10 The Human Gathering's Commitment to The Future: A Special Announcement QPAT and FSE...
Thousands of Children Got Tested for Lead With Faulty Devices: What Parents Should Know | naked...
Naked Capitalism· 6 days agoFaulty lead test kits made by Magellan Diagnostics may have been used as late as 2021 to test children for exposure to the toxic metal. The company agreed to pay $42 million to settle criminal charges that it concealed malfunctions.
Jaguar Health to Report Pivotal Phase 3 OnTarget Trial Results for its Cancer Supportive Care Drug...
Digital Journal· 3 days agoInvestor webcast on or before July 23 will include updates on Jaguar's cancer supportive care portfolio, including participation from Jaguar scientific team, patient advocates ...
Lantern Pharma secures Japan patent for cancer drug By Investing.com
Investing.com· 2 days agoThe Japan Patent Office issued the certificate for the molecule, which is currently in a Phase 1...
4Moving Biotech announces successful results from its Lasare Phase I 4P004 Clinical Trial...
Benzinga· 5 days agoLasare Phase I clinical trial demonstrated acceptable safety and tolerability profiles of 4P004 intra-articular liraglutide for treating knee osteoarthritis 4Moving Biotech received constructive pre-IND guidance
Avidity Announces Unprecedented AOC 1020 Data from Phase 1/2 FORTITUDE™ Trial Demonstrating Greater...
Morningstar· 3 days agoAvidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs™), today announced ...